单基因病植入前遗传学检测的应用情况
该调查研究纳入2010至2018年间在学术中心接受单基因病植入前遗传学检测(PGT-M)咨询的遗传高风险患者,通过电子问卷调查利用率和决策因素。使用PGT-M者中72.1%至少有一次活产或研究期间妊娠,满意度高,84.1%愿意未来再次使用。
要点
- 接受PGT-M咨询的遗传高风险患者中89.8%选择使用该技术。
- 决策最重要因素为咨询信息、检测准确性、避免患儿痛苦及避免终止妊娠。
- 主要障碍为经济负担和IVF/PGT-M流程复杂性。
核心结论
- 大多数接受PGT-M咨询的患者尽管面临经济负担和流程复杂性仍选择使用该技术。
- 探索影响患者决策的因素有助于定制咨询并优化整体体验。
研究设计与样本
- 调查研究,在学术中心进行,对象为2010年1月至2018年间因遗传风险接受PGT-M咨询的患者。
- 通过电子问卷调查人口学、遗传史、咨询体验、决策过程和满意度,受访者49名。
主要发现
- 受访者中PGT-M利用率为89.8%。
- 决策最重要因素包括咨询提供的信息、PGT-M后检测结果的准确性、避免患儿的痛苦和避免终止受累妊娠。
- 主要障碍包括经济负担和IVF/PGT-M流程的整体复杂性。
- 使用PGT-M者(n=44)中72.1%至少有一次活产或研究期间妊娠,84.1%的夫妇未来妊娠会再次使用IVF/PGT-M。
关键数值与推荐
- PGT-M利用率89.8%(49名受访者)。
- 使用PGT-M者中72.1%至少一次活产或研究期间妊娠(n=44)。
- 84.1%未来妊娠会使用IVF/PGT-M。
临床怎么用
- 咨询时应提供充分信息,强调检测准确性及避免患儿痛苦和终止妊娠的获益。
- 需关注经济负担和流程复杂性对患者决策的阻碍,并针对性支持。
- 有活产者的满意度更高,可据此优化患者体验。
局限性
- 样本量较小(n=49),可能限制结果的普遍性。
- 为单中心调查研究,存在选择偏倚可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the rate of utilization, factors influencing the decision-making process, and patient satisfaction with preimplantation genetic diagnosis for monogenic disorders (PGT-M). DESIGN: Survey study. SETTING: Academic center. PATIENT(S): Genetically at-risk patients seen for PGT-M consultation between January 2010 and 2018. INTERVENTION(S): Electronic survey including demographics, genetic history, consultation experience, decision-making process, and satisfaction with PGT-M process. MAIN OUTCOME MEASURE(S): Rate of utilization of PGT-M, importance of decision-making factors, and satisfaction with PGT-M process. RESULT(S): Among survey respondents (n = 49), the rate of utilization of PGT-M after consultation was 89.8%. Ninety-three percent of participants decided whether to pursue PGT-M within 3 months of consultation. Factors that were considered most important to this decision-making process included information provided at consultation, accuracy of test results after PGT-M, avoidance of suffering of an affected child, and ability to avoid termination of an affected pregnancy. Key barriers to utilization included financial burden and overall complexity of the in vitro fertilization (IVF)/PGT-M process. Of those utilizing PGT-M (n = 44), 72.1% had at least one live birth or were pregnant during the study period. Satisfaction with PGT-M was high, and most couples would use IVF/PGT-M for a future pregnancy (84.1%). Participants with a live birth were more satisfied with the PGT-M process than those who had no live birth. CONCLUSION(S): Most patients seeking consultation for PGT-M were likely to pursue this technology despite financial burden and complexity of the process. Exploring factors that influence patient decision-making regarding PGT-M is important for tailoring the consultation and optimizing the overall experience.
引用
- Lee I, Alur-Gupta S, Gallop R, et al. Utilization of preimplantation genetic testing for monogenic disorders. Fertil Steril. 2020. PMID: 33040985. doi:10.1016/j.fertnstert.2020.05.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。